Antimicrobial Stewardship Programs (ASPs) in Hospital and Outpatient Settings: The Devil Is in the Details
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 1714
Special Issue Editor
Special Issue Information
Dear Colleagues,
The aim of this Special Issue is to collate international findings of studies investigating antimicrobial stewardship (AMS).
The governments of all countries are projected to face escalating healthcare costs attributed to antimicrobial resistance (AMR). Encouraging the optimal use of antimicrobials through antimicrobial stewardship (ASP) can help to ensure the ideal utilization of these limited resources. Additionally, there is ample evidence to suggest that ASP implementation can assist in cost saving, primarily by decreasing intravenous (IV) antimicrobial consumption.
Many LMICs, including South Africa, are facing healthcare challenges (esp. infectious diseases), especially at entry-level primary healthcare (PHC) facilities, where antimicrobial stewardship activities and ASPs have not yet been fully implemented. Consequently, it is important to draw attention to the challenges faced in improving antimicrobial prescription across different countries and to address these in order to reduce AMR in all health care facilities
We welcome manuscripts based on all aspects regarding the main enablers and barriers of antimicrobial stewardship programmes in both LMICs and other countries. Areas of particular interest include the initiation of ASPs, outcome measures of ASPs (to determine their success or failure), knowledge and perceptions of ASPs, the role of One Health interventions in antimicrobial stewardship programmes, and vaccination in antimicrobial stewardship.
Prof. Dr. Natalie Schellack
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
